These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 10426994)

  • 21. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
    Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
    J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.
    Li P; Morris DL; Willcox BE; Steinle A; Spies T; Strong RK
    Nat Immunol; 2001 May; 2(5):443-51. PubMed ID: 11323699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of V gamma 9V delta 2 T cells by NKG2D.
    Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
    J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ULBP4 is a novel ligand for human NKG2D.
    Chalupny NJ; Sutherland CL; Lawrence WA; Rein-Weston A; Cosman D
    Biochem Biophys Res Commun; 2003 May; 305(1):129-35. PubMed ID: 12732206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
    Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
    Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.
    Roda-Navarro P; Reyburn HT
    J Biol Chem; 2009 Jun; 284(24):16463-16472. PubMed ID: 19329438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning and characterization of pig immunoreceptor DAP10 and NKG2D.
    Yim D; Jie HB; Sotiriadis J; Kim YS; Kim KS; Rothschild MF; Lanier LL; Kim YB
    Immunogenetics; 2001 Apr; 53(3):243-9. PubMed ID: 11398969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
    Cerwenka A; Bakker AB; McClanahan T; Wagner J; Wu J; Phillips JH; Lanier LL
    Immunity; 2000 Jun; 12(6):721-7. PubMed ID: 10894171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
    Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
    J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UL16 binding proteins.
    Cao W; He W
    Immunobiology; 2004; 209(3):283-90. PubMed ID: 15518340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells.
    Nitahara A; Shimura H; Ito A; Tomiyama K; Ito M; Kawai K
    J Invest Dermatol; 2006 May; 126(5):1052-8. PubMed ID: 16484989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
    J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
    Horng T; Bezbradica JS; Medzhitov R
    Nat Immunol; 2007 Dec; 8(12):1345-52. PubMed ID: 17952078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells.
    Quatrini L; Molfetta R; Zitti B; Peruzzi G; Fionda C; Capuano C; Galandrini R; Cippitelli M; Santoni A; Paolini R
    Sci Signal; 2015 Oct; 8(400):ra108. PubMed ID: 26508790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.
    Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
    J Immunol; 2002 Apr; 168(7):3155-64. PubMed ID: 11907067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structural basis for intramembrane assembly of an activating immunoreceptor complex.
    Call ME; Wucherpfennig KW; Chou JJ
    Nat Immunol; 2010 Nov; 11(11):1023-9. PubMed ID: 20890284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways.
    Coudert JD; Scarpellino L; Gros F; Vivier E; Held W
    Blood; 2008 Apr; 111(7):3571-8. PubMed ID: 18198346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.
    Oppenheim DE; Roberts SJ; Clarke SL; Filler R; Lewis JM; Tigelaar RE; Girardi M; Hayday AC
    Nat Immunol; 2005 Sep; 6(9):928-37. PubMed ID: 16116470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    Diefenbach A; Jamieson AM; Liu SD; Shastri N; Raulet DH
    Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.